Her2 Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Her2 stocks.

Her2 Stocks Recent News

Date Stock Title
May 3 GTHX G1 Therapeutics First Quarter 2024 Earnings: Revenues Disappoint
May 3 PBYI Puma Biotechnology Inc (PBYI) Q1 2024 Earnings Call Transcript Highlights: A Detailed Review of ...
May 3 PBYI Puma Biotechnology, Inc. (PBYI) Q1 2024 Earnings Call Transcript
May 3 ZYME Zymeworks Inc. (ZYME) Q1 2024 Earnings Call Transcript
May 2 PBYI Puma Biotechnology, Inc. 2024 Q1 - Results - Earnings Call Presentation
May 2 PBYI Puma Biotechnology Inc (PBYI) Reports Q1 Financial Results, Misses Analyst Revenue and EPS Forecasts
May 2 ZYME Zymeworks files automatic mixed securities shelf
May 2 PBYI Puma Biotechnology Non-GAAP EPS of -$0.05 beats by $0.10, revenue of $43.8M misses by $5.25M
May 2 ZYME Zymeworks GAAP EPS of -$0.42 misses by $0.10, revenue of $10.03M misses by $6.4M
May 2 PBYI Puma Biotechnology Reports First Quarter Financial Results
May 2 ZYME Zymeworks Provides Corporate Update and Reports First Quarter 2024 Financial Results
May 2 GTHX G1 Therapeutics, Inc. (NASDAQ:GTHX) Q1 2024 Earnings Call Transcript
May 2 GTHX G1 Therapeutics Inc (GTHX) Q1 2024 Earnings Call Transcript Highlights: Strong Revenue Growth ...
May 2 GTHX Q1 2024 G1 Therapeutics Inc Earnings Call
May 1 PBYI Puma Biotechnology Q1 2024 Earnings Preview
May 1 ZYME Zymeworks Q1 2024 Earnings Preview
May 1 GTHX G1 Therapeutics, Inc. (GTHX) Q1 2024 Earnings Call Transcript
May 1 GTHX G1 Therapeutics and Pepper Bio sign license agreement for lerociclib
May 1 GTHX G1 Therapeutics Inc (GTHX) Q1 2024 Earnings: Close Alignment with Analyst Revenue Projections
May 1 GTHX G1 Therapeutics (GTHX) Reports Q1 Loss, Lags Revenue Estimates
Her2

Receptor tyrosine-protein kinase erbB-2, also known as CD340 (cluster of differentiation 340), proto-oncogene Neu, Erbb2 (rodent), or ERBB2 (human), is a protein that in humans is encoded by the ERBB2 gene. ERBB is abbreviated from erythroblastic oncogene B, a gene isolated from avian genome. It is also frequently called HER2 (from human epidermal growth factor receptor 2) or HER2/neu.HER2 is a member of the human epidermal growth factor receptor (HER/EGFR/ERBB) family. Amplification or over-expression of this oncogene has been shown to play an important role in the development and progression of certain aggressive types of breast cancer. In recent years the protein has become an important biomarker and target of therapy for approximately 30% of breast cancer patients.

Browse All Tags